Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure

Circulation

Volumn 100, Issue 19 SUPPL., 1999, Pages

  Bartling, Babett ^a   Milting, Hendrik ^a   Schumann, Heike ^a   Darmer, Dorothea ^a   Arusoglu, Lativ ^b   Koerner, Michael Matthias ^b   El Banayosy, Aly ^b   Koerfer, Reiner ^b   Holtz, Juergen ^a   Zerkowski, Hans Reinhard ^a,c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Apoptosis; Calcium; Heart failure; Heart assist device

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ATRIAL NATRIURETIC FACTOR; CALCIUM; FAS ANTIGEN; MESSENGER RNA; PROTEIN BCL X; SODIUM CALCIUM EXCHANGE PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; EXPLANT; GENE EXPRESSION; HEART ASSIST DEVICE; HEART DILATATION; HEART FAILURE; HEART MUSCLE CELL; HEART TRANSPLANTATION; HEART VENTRICLE OVERLOAD; HEMODYNAMICS; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; APOPTOSIS; CALCIUM; GENE EXPRESSION REGULATION; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; VENTRICULAR FUNCTION, LEFT;

EID: 0345633707     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. McCarthy PM. Heartmate implantable left ventricular assist device: bridge to transplantation and future applications. Ann Thorac Surg. 1995; 59:846-851.
2. Levin H, Chen J, Oz M, Catanese K, Krum H, Goldsmith R, Packer M, Rose E. Potential for left ventricular assist devices as out-patient therapy while awaiting transplantation. Ann Thorac Surg. 1994;58:1515-1520.
3. Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin HR, Kayne HL. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 1995;222:327-338.
4. Katz AM. The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart. Ann Intern Med. 1994;121:363-371.
5. Westaby S, Coats AJS. Mechanical bridge to myocardial recovery. Eur Heart J. 1998;19:541-547.
6. Mueller J, Wallukat G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theodoridis V, Loebe M, Meyer R, Hetzer R. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997;96:542-549.
7. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247-2259.
8. Narula J, Haider N, Virmani R, DiSalvo T, Kologdie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec W, Khaw BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
9. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 1997;336:1131-1141.
10. Bartling B, Schumann H, Holtz J, Grapow M, Zerkowski H-R, Darmer D. Effect of ACE inhibitors on the expression of Bcl-2 related genes in failing human left ventricular myocardium. Circulation. 1998;98(suppl I):I-75. Abstract.
11. Schumann H, Morawietz H, Hakim K, Zerkowski H-R, Eschenhagen T, Holtz J, Darmer D. Alternative splicing of the primary Fas transcript generating soluble Fas antagonists is suppressed in the failing human ventricular myocardium. Biochem Biophys Res Commun. 1997;239:794-798.
12. Cascino I, Papoff G, De Maria R, Testi R, Ruberti G. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J Immunol. 1996;156:13-17.
13. Reed JC. Mechanisms of Bcl-2 family proteins function and dysfunction in health and disease. Behring Inst Mitt. 1996;97:72-100.
14. L regulates the membrane potential and volume homeostasis of mitochondria. Cell. 1997;91:627-637.
15. L as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci U S A. 1997;94: 6939-6942.
16. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132-1136.
17. Wang X, Studzinski GP. Anti-apoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp Cell Res. 1997;235: 210-217.
18. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with endstage cardiomyopathy by prolonged mechanical offloading. Circulation. 1995;91:2717-2720.
19. Nakatani S, McCarthy P, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD. Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. J Am Coll Cardiol. 1996;27:894-901.
20. 2+-ATPase gene expression in the human ventricle during endstage human heart failure. J Clin Invest. 1990;85:305-309.
21. 2+ exchanger in end-stage human heart failure. Circ Res. 1994;75:443-453.
22. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter W. Isolation of biologically active ribonucleic acid isolated from sources enriched in ribonuclease. Biochemistry. 1979;18:5294-5299.
23. Corbi AL, Miller LJ, O'Connor K, Larson RS, Springer TA. cDNA cloning and complete primary structure of the alpha subunit of a leukocyte adhesion glycoprotein, p150,95. EMBO J. 1987;6:4023-4028.
24. Knowlton KU. Atrial natriuretic factor: a molecular marker for cardiac specific, embryonic, and inducible gene expression. Heart Failure. 1992; 8:121-128.
25. Wu CF, Bishopric NH, Pratt RE. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem. 1997;272: 14860-14866.
26. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest. 1998;101:1326-1342.
27. Fortuno MA, Ravassa S, Etayo JC, Diez J. Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats: effects of AT1 blockade with losartan. Hypertension. 1998; 32:280-286.
28. Goussev A, Sharov VG, Shimoyama H, Tanimura M, Lesch M, Goldstein S, Sabbah HN. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol. 1998;275:H626-H631.
29. Spanier T, Wang J, Oz M, Packer M, Skopicki HA. Improvement in the apoptotic regulatory paradigm with left ventricular device (LVAD) implantation. Circulation. 1998;98(suppl I):I-719. Abstract.
30. 2+-ATPase in failing and nonfailing human myocardium. Circ Res. 1994;75:434-442.
31. Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H, Minami K, Just H, Hasenfuss G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation. 1995;92:1169-1178.
32. Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, Marcris MP, Delgado R, Buja M. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996;62:675-682.